Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | CDK9 | P50750 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.58 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | TGM2 | P21980 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3271860 | 1.00 | EPHX2 (0.64) | EPHX2TP53EPHX1TSHRCDK9 | |
| SCHEMBL9112963 | 0.84 | NAPRT (0.54) | EPHX2TP53EPHX1TSHRCDK9 | |
| SCHEMBL9112947 | 0.84 | NAPRT (0.54) | EPHX2TP53EPHX1TSHRCDK9 | |
| SCHEMBL7416207 | 0.84 | EPHX1 (0.52) | EPHX2TP53EPHX1TSHRCDK9 | |
| SCHEMBL4214608 | 0.83 | NAPRT (0.57) | EPHX2TP53EPHX1TSHRCDK9 | |
| SCHEMBL3196733 | 0.80 | ALDH1A1 (0.52) | SMN1; SMN2HSD17B10MAPTALDH1A1GAA | |
| SCHEMBL616739 | 0.79 | PTPN11 (0.75) | EPHX2TP53EPHX1TSHRCDK9 | |
| SCHEMBL57554 | 0.78 | SMN1; SMN2 (0.70) | EPHX2TP53EPHX1TSHRCDK9 | |
| Diphenylurea SCHEMBL133103 | 0.78 | SMN1; SMN2 (1.00) | EPHX2TP53EPHX1TSHRCDK9 | |
| Benzene SCHEMBL28977956 | 0.78 | SMN1; SMN2 (0.70) | EPHX2TP53EPHX1TSHRCDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0262305-B1 | METHOD FOR THE PREPARATION OF ANILINOFUMARATE AND QUINOLINE-2,3-DICARBOXYLIC ACID | AMERICAN CYANAMID COMPANY (US) | 1990-10-31 | — | — | EP | claimed |
| US-11744150-B2 | Synthesis of aza-acenes as novel n-type materials for organic electronics | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2023-08-29 | — | — | US | disclosed |
| US-20210313517-A1 | SYNTHESIS OF AZA-ACENES AS NOVEL N-TYPE MATERIALS FOR ORGANIC ELECTRONICS | UNITED STATES DEPARTMENT OF ENERGY | 2021-10-07 | — | — | US | disclosed |
| EP-2805363-A1 | SYNTHESIS OF AZA-ACENES AS NOVEL N-TYPE MATERIALS FOR ORGANIC ELECTRONICS | University of Southern California (US) | 2014-11-26 | — | — | EP | disclosed |
| US-20130187136-A1 | SYNTHESIS OF AZA-ACENES AS NOVEL N-TYPE MATERIALS FOR ORGANIC ELECTRONICS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2013-07-25 | — | — | US | disclosed |
| WO-2013110057-A1 | SYNTHESIS OF AZA-ACENES AS NOVEL N-TYPE MATERIALS FOR ORGANIC ELECTRONICS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2013-07-25 | — | — | WO | disclosed |
| US-7691197-B2 | Method of preparing yellow pigments | CABOT CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| WO-2007047975-A2 | METHOD OF PREPARING YELLOW PIGMENTS | CABOT CORPORATION (US) | 2007-04-26 | — | — | WO | disclosed |
| US-20070089641-A1 | Method of preparing yellow pigments | CABOT CORPORATION | 2007-04-26 | — | — | US | disclosed |
| EP-0402561-B1 | Process for the manufacture of anilinofumarate via chloromaleate or chlorofumarate or mixtures thereof | AMERICAN CYANAMID CO (US) | 1994-10-05 | — | — | EP | disclosed |
| EP-0309711-B1 | IMPROVED METHOD FOR THE PREPARATION OF ANILINOFUMARATE | AMERICAN CYANAMID COMPANY (US) | 1993-02-03 | — | — | EP | disclosed |
| EP-0402561-A3 | PROCESS FOR THE MANUFACTURE OF ANILINOFUMARATE VIA CHLOROMALEATE OR CHLOROFUMARATE OR MIXTURES THEREOF | AMERICAN CYANAMID COMPANY (US) | 1991-05-29 | — | — | EP | disclosed |
| EP-0402561-A2 | Process for the manufacture of anilinofumarate via chloromaleate or chlorofumarate or mixtures thereof | AMERICAN CYANAMID COMPANY (US) | 1990-12-19 | — | — | EP | disclosed |
| EP-0262305-B1 | METHOD FOR THE PREPARATION OF ANILINOFUMARATE AND QUINOLINE-2,3-DICARBOXYLIC ACID | AMERICAN CYANAMID COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0309711-A1 | Improved method for the preparation of anilinofumarate | AMERICAN CYANAMID COMPANY (US) | 1989-04-05 | — | — | EP | disclosed |
| EP-0262305-A1 | Method for the preparation of anilinofumarate and quinoline-2,3-dicarboxylic acid | AMERICAN CYANAMID COMPANY (US) | 1988-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210313517-A1 | SYNTHESIS OF AZA-ACENES AS NOVEL N-TYPE MATERIALS FOR ORGANIC ELECTRONICS | ACE2, ACE, AZI2 | EPHX2 1181/4885TP53 3616/4885EPHX1 765/4885 |
| US-20130187136-A1 | SYNTHESIS OF AZA-ACENES AS NOVEL N-TYPE MATERIALS FOR ORGANIC ELECTRONICS | ACE2, ACE, AZI2 | EPHX2 1181/4885TP53 3616/4885EPHX1 765/4885 |
| US-11744150-B2 | Synthesis of aza-acenes as novel n-type materials for organic electronics | ACE2, ACE, AZI2 | EPHX2 1181/4885TP53 3616/4885EPHX1 765/4885 |
| US-20070089641-A1 | Method of preparing yellow pigments | TYR, NQO2, RB1 | EPHX2 851/4885TP53 1199/4885EPHX1 1241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.